Search - tctmd.com

Displaying 161 - 180 of 1825

Sort: Relevancy | Date

News Conference News EuroPCR 2024

PCI for Multivessel Disease More Cost-effective Than CABG at 3 Years: FAME 3

Yael L. Maxwell

May 17, 2024

News Conference News EuroPCR 2024

Young, Low-risk Patients Fare Well With TAVI, but Beware the Bicuspids

Michael O'Riordan

May 15, 2024

Presentation EuroPCR 2024

First TAVI vs. SAVR randomised trial in younger low-risk patients with severe tricuspid or bicuspid aortic valve stenosis - results from NOTION-2

Presenter: Ole De Backer

May 15, 2024

News Conference News EuroPCR 2024

NOW PUBLISHED - Latest TAVI vs Surgery Trial Raises Eyebrows in Aortic Stenosis Plus CAD

Michael O'Riordan

May 14, 2024

Presentation EuroPCR 2024

Short Methodology Insight - NOTION-2

Presenter: Davide Capodanno

May 14, 2024

Presentation EuroPCR 2024

Diagnostic accuracy of fully automatic Murray law-based quantitative flow ratio

Presenter: Shengxian Tu

May 14, 2024

Presentation EuroPCR 2024

Diagnostic performance of fully automatic computational FFR in the CAREER study

Presenter: Shengxian Tu

May 14, 2024

Presentation EuroPCR 2024

Combining angiography and pre-specified intracoronary testing in patients with chronic coronary syndromes: the AID-ANGIO study

Presenter: Adrian Jeronimo

May 14, 2024

News Conference News EuroPCR 2024

Go Beyond Angiography in CCS to Pinpoint the Problem, Urges AID-ANGIO

Caitlin E. Cox

May 14, 2024

Presentation Fellows 2024

Case 3 & 4

Presenter: Yiannis S. Chatzizisis

April 14, 2024

Presentation Fellows 2024

Case 1 & 2

Presenter: Colin M. Barker

April 14, 2024

News Conference News ACC 2024

PREVENT Supports Early PCI for Vulnerable Plaque, With Reductions in MACE

L.A. McKeown

April 08, 2024

News Daily News

Invasive Angio Adds Nothing to CCTA Alone for Risk Prediction: ISCHEMIA

Michael O'Riordan

March 14, 2024

News Daily News

DISCHARGE Data Reassure on Use of CCTA in Older Chest-Pain Patients

Michael O'Riordan

March 04, 2024

News Daily News

High-Risk ‘Clues’ Add Heft to Calcium Scores in Primary Prevention

Michael O'Riordan

February 29, 2024

Presentation CTO 2024

Anatomy, Physiology, and Procedural Planning: All You Need Is CCTA!

Presenter: Farouc A. Jaffer

February 03, 2024

News Conference News

Real-world Data Reiterate Value of CT-First Strategy to Rule Out Obstructive CAD

L.A. McKeown

February 02, 2024

News Daily News

Deferred PCI Equally Safe When Decision-making’s Based on IVUS vs FFR

Caitlin E. Cox

December 07, 2023

News Daily News

PCI With Intravascular Imaging or Functional Testing Bests Angiography Alone

Michael O'Riordan

November 24, 2023

News Conference News AHA 2023

Placebo-Controlled ORBITA-2 Shows PCI Eases Symptoms in Stable Angina

Michael O'Riordan

November 11, 2023

Advertisement

PCI for Multivessel Disease More Cost-effective Than CABG at 3 Years: FAME 3

Young, Low-risk Patients Fare Well With TAVI, but Beware the Bicuspids

First TAVI vs. SAVR randomised trial in younger low-risk patients with severe tricuspid or bicuspid aortic valve stenosis - results from NOTION-2

NOW PUBLISHED - Latest TAVI vs Surgery Trial Raises Eyebrows in Aortic Stenosis Plus CAD

Short Methodology Insight - NOTION-2

Diagnostic accuracy of fully automatic Murray law-based quantitative flow ratio

Diagnostic performance of fully automatic computational FFR in the CAREER study

Combining angiography and pre-specified intracoronary testing in patients with chronic coronary syndromes: the AID-ANGIO study

Go Beyond Angiography in CCS to Pinpoint the Problem, Urges AID-ANGIO

Case 3 & 4

Case 1 & 2

PREVENT Supports Early PCI for Vulnerable Plaque, With Reductions in MACE

Invasive Angio Adds Nothing to CCTA Alone for Risk Prediction: ISCHEMIA

DISCHARGE Data Reassure on Use of CCTA in Older Chest-Pain Patients

High-Risk ‘Clues’ Add Heft to Calcium Scores in Primary Prevention

Anatomy, Physiology, and Procedural Planning: All You Need Is CCTA!

Real-world Data Reiterate Value of CT-First Strategy to Rule Out Obstructive CAD

Deferred PCI Equally Safe When Decision-making’s Based on IVUS vs FFR

PCI With Intravascular Imaging or Functional Testing Bests Angiography Alone

Placebo-Controlled ORBITA-2 Shows PCI Eases Symptoms in Stable Angina

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content